ORANGE BELGIUM (OBEL.BR) Stock Fundamental Analysis

Europe • Euronext Brussels • EBR:OBEL • BE0003735496

19.5 EUR
+0.25 (+1.3%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

3

OBEL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 6 industry peers in the Wireless Telecommunication Services industry. While OBEL is still in line with the averages on profitability rating, there are concerns on its financial health. OBEL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • OBEL had positive earnings in the past year.
  • In the past year OBEL had a positive cash flow from operations.
  • OBEL had positive earnings in each of the past 5 years.
  • OBEL had a positive operating cash flow in each of the past 5 years.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • OBEL has a Return On Assets (0.93%) which is comparable to the rest of the industry.
  • The Return On Equity of OBEL (3.88%) is better than 66.67% of its industry peers.
  • With a decent Return On Invested Capital value of 3.63%, OBEL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for OBEL is below the industry average of 6.49%.
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROIC 3.64%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • With a Profit Margin value of 1.89%, OBEL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of OBEL has declined.
  • OBEL's Operating Margin of 7.62% is in line compared to the rest of the industry. OBEL outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of OBEL has grown nicely.
  • The Gross Margin of OBEL (68.11%) is better than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of OBEL has grown nicely.
Industry RankSector Rank
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OBEL is destroying value.
  • The number of shares outstanding for OBEL has been increased compared to 1 year ago.
  • Compared to 5 years ago, OBEL has more shares outstanding
  • The debt/assets ratio for OBEL has been reduced compared to a year ago.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • OBEL has an Altman-Z score of 0.96. This is a bad value and indicates that OBEL is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.96, OBEL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • OBEL has a debt to FCF ratio of 23.91. This is a negative value and a sign of low solvency as OBEL would need 23.91 years to pay back of all of its debts.
  • OBEL has a Debt to FCF ratio of 23.91. This is amonst the worse of the industry: OBEL underperforms 83.33% of its industry peers.
  • OBEL has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.92, OBEL is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Altman-Z 0.96
ROIC/WACC0.69
WACC5.28%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 0.49 indicates that OBEL may have some problems paying its short term obligations.
  • OBEL's Current ratio of 0.49 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
  • A Quick Ratio of 0.46 indicates that OBEL may have some problems paying its short term obligations.
  • OBEL has a worse Quick ratio (0.46) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.46
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • OBEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 780.62%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -9.64% on average over the past years.
  • The Revenue has decreased by -0.39% in the past year.
  • Measured over the past years, OBEL shows a quite strong growth in Revenue. The Revenue has been growing by 8.26% on average per year.
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%

3.2 Future

  • The Earnings Per Share is expected to decrease by -12.63% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 2.24% on average over the next years.
EPS Next Y-6.88%
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%
EPS Next 5Y-12.63%
Revenue Next Year4.91%
Revenue Next 2Y2.42%
Revenue Next 3Y3.44%
Revenue Next 5Y2.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 32.50, the valuation of OBEL can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of OBEL indicates a slightly more expensive valuation: OBEL is more expensive than 66.67% of the companies listed in the same industry.
  • OBEL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.92, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 93.26 indicates a quite expensive valuation of OBEL.
  • Based on the Price/Forward Earnings ratio, OBEL is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. OBEL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 32.5
Fwd PE 93.26
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • OBEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OBEL is cheaper than 83.33% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of OBEL indicates a somewhat cheap valuation: OBEL is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.95
EV/EBITDA 5.39
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The decent profitability rating of OBEL may justify a higher PE ratio.
  • OBEL's earnings are expected to decrease with -36.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OBEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORANGE BELGIUM

EBR:OBEL (2/6/2026, 7:00:00 PM)

19.5

+0.25 (+1.3%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)N/A
Earnings (Next)02-06
Inst Owners5.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.31B
Revenue(TTM)1.98B
Net Income(TTM)37.35M
Analysts77.78
Price Target20.57 (5.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)184.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.36%
Valuation
Industry RankSector Rank
PE 32.5
Fwd PE 93.26
P/S 0.66
P/FCF 14.95
P/OCF 2.78
P/B 1.37
P/tB N/A
EV/EBITDA 5.39
EPS(TTM)0.6
EY3.08%
EPS(NY)0.21
Fwd EY1.07%
FCF(TTM)1.3
FCFY6.69%
OCF(TTM)7.01
OCFY35.97%
SpS29.36
BVpS14.28
TBVpS-9.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.88
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROCE 4.85%
ROIC 3.64%
ROICexc 3.7%
ROICexgc 7.68%
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
FCFM 4.44%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
ROICexc(3y)4.56%
ROICexc(5y)5.09%
ROICexgc(3y)11.41%
ROICexgc(5y)10.53%
ROCE(3y)6.22%
ROCE(5y)6.69%
ROICexgc growth 3Y-7.87%
ROICexgc growth 5Y2.19%
ROICexc growth 3Y-16.49%
ROICexc growth 5Y-3.51%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Debt/EBITDA 2.97
Cap/Depr 81.82%
Cap/Sales 19.45%
Interest Coverage 1.49
Cash Conversion 76.13%
Profit Quality 235.44%
Current Ratio 0.49
Quick Ratio 0.46
Altman-Z 0.96
F-Score7
WACC5.28%
ROIC/WACC0.69
Cap/Depr(3y)156.85%
Cap/Depr(5y)119.41%
Cap/Sales(3y)34.82%
Cap/Sales(5y)26.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)780.62%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%119.69%
EPS Next Y-6.88%
EPS Next 2Y-36.27%
EPS Next 3Y-36.38%
EPS Next 5Y-12.63%
Revenue 1Y (TTM)-0.39%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%-1.52%
Revenue Next Year4.91%
Revenue Next 2Y2.42%
Revenue Next 3Y3.44%
Revenue Next 5Y2.24%
EBIT growth 1Y12.37%
EBIT growth 3Y22.15%
EBIT growth 5Y18.64%
EBIT Next Year291.76%
EBIT Next 3Y55.8%
EBIT Next 5Y30.59%
FCF growth 1Y116.96%
FCF growth 3Y-9.07%
FCF growth 5Y-7.65%
OCF growth 1Y24.22%
OCF growth 3Y10.98%
OCF growth 5Y8.17%

ORANGE BELGIUM / OBEL.BR FAQ

Can you provide the ChartMill fundamental rating for ORANGE BELGIUM?

ChartMill assigns a fundamental rating of 3 / 10 to OBEL.BR.


Can you provide the valuation status for ORANGE BELGIUM?

ChartMill assigns a valuation rating of 3 / 10 to ORANGE BELGIUM (OBEL.BR). This can be considered as Overvalued.


How profitable is ORANGE BELGIUM (OBEL.BR) stock?

ORANGE BELGIUM (OBEL.BR) has a profitability rating of 6 / 10.


How financially healthy is ORANGE BELGIUM?

The financial health rating of ORANGE BELGIUM (OBEL.BR) is 0 / 10.


What is the earnings growth outlook for ORANGE BELGIUM?

The Earnings per Share (EPS) of ORANGE BELGIUM (OBEL.BR) is expected to decline by -6.88% in the next year.